Advertisement
Advertisement

ATRC

ATRC logo

AtriCure, Inc.

48.54
USD
Sponsored
-0.73
-1.48%
Aug 28, 16:00 UTC -4
Closed
exchange

After-Market

48.58

+0.04
+0.08%

ATRC Earnings Reports

Positive Surprise Ratio

ATRC beat 33 of 43 last estimates.

77%

Next Report

Date of Next Report
Oct 27, 2026
Estimate for Q3 26 (Revenue/ EPS)
$154.24M
/
-$0.05
Implied change from Q2 26 (Revenue/ EPS)
+0.41%
/
-127.78%
Implied change from Q3 25 (Revenue/ EPS)
+14.87%
/
+400.00%

AtriCure, Inc. earnings per share and revenue

On Jul 23, 2026, ATRC reported earnings of 0.18 USD per share (EPS) for Q2 26, beating the estimate of 0.00 USD, resulting in a 3900.00% surprise. Revenue reached 153.60 million, compared to an expected 154.88 million, with a -0.82% difference. The market reacted with a +6.18% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 11 analysts forecast an EPS of -0.05 USD, with revenue projected to reach 154.24 million USD, implying an decrease of -127.78% EPS, and increase of 0.41% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Agilent Technologies Inc.
Report Date
Aug 26, 2026 For Q3 26
Estimate
$1.51
Actual
$1.62
Surprise
+6.90%
logo
Phibro Animal Health Corporation Class A
Report Date
Aug 26, 2026 For Q4 26
Estimate
$0.72
Actual
$0.85
Surprise
+16.87%
FAQ
For Q2 2026, AtriCure, Inc. reported EPS of $0.18, beating estimates by 3900%, and revenue of $153.60M, -0.82% below expectations.
The stock price moved up 6.18%, changed from $33.00 before the earnings release to $35.04 the day after.
The next earning report is scheduled for Oct 27, 2026.
Based on 11 analysts, AtriCure, Inc. is expected to report EPS of -$0.05 and revenue of $154.24M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement